The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells

Cytokine

Volumn 59, Issue 2, 2012, Pages 286-293

  Wong, Chi Hang ^a   Mak, Grace Wing Yan ^b   Li, Man Shan ^b   Tsui, Stephen Kwok Wing ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

FHL2; IL 6; Interleukin 6; MAPK; NF B; P38 MAPK; Skeletal myoblasts

Indexed keywords

FHL2 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIM PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE OVEREXPRESSION; GENE SILENCING; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; I-KAPPA B PROTEINS; INTERLEUKIN-6; LIM-HOMEODOMAIN PROTEINS; LUCIFERASES; MAP KINASE SIGNALING SYSTEM; MICE; MUSCLE CELLS; MUSCLE PROTEINS; MYOBLASTS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PROTEOLYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84862339130     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.044     Document Type: Article

References (45)

1. Chan K.K., Tsui S.K., Lee S.M., Luk S.C., Liew C.C., Fung K.P., et al. Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 1998, 210:345-350.
2. Johannessen M., Moller S., Hansen T., Moens U., Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 2006, 63:268-284.
3. Sun J., Yan G., Ren A., You B., Liao J.K. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1. Circ Res 2006, 99:468-476.
4. Amann T., Egle Y., Bosserhoff A.K., Hellerbrand C. FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. Oncol Rep 2010, 23:1669-1674.
5. Kleiber K., Strebhardt K., Martin B.T. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target. Anticancer Res. 2007, 27:55-61.
6. Ng C.F., Ng P.K., Lui V.W., Li J., Chan J.Y., Fung K.P., et al. FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. Cancer Lett 2011, 304:97-106.
7. Chu P.H., Bardwell W.M., Gu Y., Ross J., Chen J. FHL2 (SLIM3) is not essential for cardiac development and function. Mol Cell Biol 2000, 20:7460-7462.
8. Chu P.H., Ruiz-Lozano P., Zhou Q., Cai C., Chen J. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev 2000, 95:259-265.
9. Scholl F.A., McLoughlin P., Ehler E., de Giovanni C., Schafer B.W. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol 2000, 151:495-506.
10. Muller J.M., Metzger E., Greschik H., Bosserhoff A.K., Mercep L., Buettner R., et al. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 2002, 21:736-748.
11. Gabriel B., Mildenberger S., Weisser C.W., Metzger E., Gitsch G., Schule R., et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res 2004, 24:921-927.
12. Ng C.F., Zhou W.J., Ng P.K., Li M.S., Ng Y.K., Lai P.B., et al. Characterization of human FHL2 transcript variants and gene expression regulation in hepatocellular carcinoma. Gene 2011, 481:41-47.
13. Wan S., Yim A.P., Wong C.K., Arifi A.A., Yip J.H., Ng C.S., et al. Expression of FHL2 and cytokine messenger RNAs in human myocardium after cardiopulmonary bypass. Int J Cardiol 2002, 86:265-272.
14. Morlon A., Sassone-Corsi P. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci USA 2003, 100:3977-3982.
15. Fimia G.M., De Cesare D., Sassone-Corsi P. A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol Cell Biol 2000, 20:8613-8622.
16. Stilo R., Leonardi A., Formisano L., Di Jeso B., Vito P., Liguoro D. TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. FEBS Lett 2002, 521:165-169.
17. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998, 128:127-137.
18. Yassin M.M., Harkin D.W., Barros D'Sa A.A., Halliday M.I., Rowlands B.J. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg 2002, 26:115-121.
19. Kanda T., Sakamoto H., McManus B.M., Sakamaki T., Nagai R., Suzuki T., et al. Interleukin-6 secreted from human myxoma reduces murine viral myocarditis. Life Sci 1996, 58:1705-1712.
20. Mann D.L. Stress activated cytokines and the heart. Cytokine Growth Factor Rev 1996, 7:341-354.
21. Gwechenberger M., Mendoza L.H., Youker K.A., Frangogiannis N.G., Smith C.W., Michael L.H., et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999, 99:546-551.
22. Saito S., Aikawa R., Shiojima I., Nagai R., Yazaki Y., Komuro I. Endothelin-1 induces expression of fetal genes through the interleukin-6 family of cytokines in cardiac myocytes. FEBS Lett 1999, 456:103-107.
23. Craig R., Larkin A., Mingo A.M., Thuerauf D.J., Andrews C., McDonough P.M., et al. P38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 2000, 275:23814-23824.
24. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008, 88:1379-1406.
25. Gallucci R.M., Simeonova P.P., Matheson J.M., Kommineni C., Guriel J.L., Sugawara T., et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000, 14:2525-2531.
26. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782-784.
27. Wang C.Y., Mayo M.W., Baldwin A.S. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787.
28. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20.
29. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl.):S81-S96.
30. Maulik N., Sato M., Price B.D., Das D.K. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998, 429:365-369.
31. Puri P.L., Sartorelli V. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J Cell Physiol 2000, 185:155-173.
32. Baeza-Raja B., Munoz-Canoves P. P38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell 2004, 15:2013-2026.
33. Martin B., Schneider R., Janetzky S., Waibler Z., Pandur P., Kuhl M., et al. The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J Cell Biol 2002, 159:113-122.
34. Wong C.K., Cheung P.F., Ip W.K., Lam C.W. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 2005, 33:186-194.
35. Baccam M., Woo S.Y., Vinson C., Bishop G.A. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J Immunol 2003, 170:3099-3108.
36. Pramanik R., Qi X., Borowicz S., Choubey D., Schultz R.M., Han J., et al. P38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem 2003, 278:4831-4839.
37. Rolli M., Kotlyarov A., Sakamoto K.M., Gaestel M., Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. J Biol Chem 1999, 274:19559-19564.
38. Jonsdottir I.H., Schjerling P., Ostrowski K., Asp S., Richter E.A., Pedersen B.K. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 2000, 528(Pt 1):157-163.
39. Pedersen B.K., Steensberg A., Fischer C., Keller C., Ostrowski K., Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 2001, 7:18-31.
40. Gokhale R., Chandrashekara S., Vasanthakumar K.C. Cytokine response to strenuous exercise in athletes and non-athletes - an adaptive response. Cytokine 2007, 40:123-127.
41. Austin L., Bower J., Kurek J., Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci 1992, 112:185-191.
42. Baron P., Galimberti D., Meda L., Scarpini E., Conti G., Cogiamanian F., et al. Production of IL-6 by human myoblasts stimulated with Abeta: relevance in the pathogenesis of IBM. Neurology 2001, 57:1561-1565.
43. Sheng Z., Knowlton K., Chen J., Hoshijima M., Brown J.H., Chien K.R. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 1997, 272:5783-5791.
44. Stephanou A., Brar B., Heads R., Knight R.D., Marber M.S., Pennica D., et al. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol 1998, 30:849-855.
45. Conejo R., Valverde A.M., Benito M., Lorenzo M. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J Cell Physiol 2001, 186:82-94.